PAVmed (PAVM) Retained Earnings (2015 - 2025)

PAVmed's Retained Earnings history runs 11 years deep, the most recent figure standing at -$258.7 million for Q4 2025.

• In Q4 2025, Retained Earnings fell 1.48% year-over-year to -$258.7 million; the TTM figure through Dec 2025 stood at -$258.7 million (down 1.48% YoY), while the FY2025 annual figure was -$258.7 million, down 1.48% from the prior year.
• Retained Earnings was -$258.7 million for Q4 2025 at PAVmed, down from -$256.9 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of -$97.8 million in Q1 2021 to a low of -$320.6 million in Q2 2024.
• Historically, Retained Earnings has averaged -$221.5 million across 5 years, with a median of -$246.2 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Retained Earnings sank 70.72% in 2022, then advanced 23.39% in 2025.
• A 5-year view of Retained Earnings shows it stood at -$138.9 million in 2021, then tumbled by 64.26% to -$228.2 million in 2022, then dropped by 29.04% to -$294.4 million in 2023, then advanced by 13.4% to -$255.0 million in 2024, then dropped by 1.48% to -$258.7 million in 2025.
• The last three Retained Earnings figures came in at -$258.7 million (Q4 2025), -$256.9 million (Q3 2025), and -$250.6 million (Q2 2025), per Business Quant data.